Attached files
| file | filename |
|---|---|
| S-1 - REGISTRATION STATEMENT ON FORM S-1 - Rain Therapeutics Inc. | d26404ds1.htm |
| EX-10.12 - EX-10.12 - Rain Therapeutics Inc. | d26404dex1012.htm |
| EX-10.11 - EX-10.11 - Rain Therapeutics Inc. | d26404dex1011.htm |
| EX-10.10 - EX-10.10 - Rain Therapeutics Inc. | d26404dex1010.htm |
| EX-10.9 - EX-10.9 - Rain Therapeutics Inc. | d26404dex109.htm |
| EX-10.8 - EX-10.8 - Rain Therapeutics Inc. | d26404dex108.htm |
| EX-10.7 - EX-10.7 - Rain Therapeutics Inc. | d26404dex107.htm |
| EX-10.6 - EX-10.6 - Rain Therapeutics Inc. | d26404dex106.htm |
| EX-10.5 - EX-10.5 - Rain Therapeutics Inc. | d26404dex105.htm |
| EX-10.2 - EX-10.2 - Rain Therapeutics Inc. | d26404dex102.htm |
| EX-10.1 - EX-10.1 - Rain Therapeutics Inc. | d26404dex101.htm |
| EX-4.2 - EX-4.2 - Rain Therapeutics Inc. | d26404dex42.htm |
| EX-3.3 - EX-3.3 - Rain Therapeutics Inc. | d26404dex33.htm |
| EX-3.1 - EX-3.1 - Rain Therapeutics Inc. | d26404dex31.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 5, 2021, in the Registration Statement on Form S-1 and related Prospectus of Rain Therapeutics Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
San Diego, California
April 2, 2021